Higher cost means lower adherence to aromatase inhibitors
Women were more likely to discontinue taking aromatase inhibitors if the out-of-pocket costs were higher, a research study suggested. Generic drugs, which have lower copayments,
Women were more likely to discontinue taking aromatase inhibitors if the out-of-pocket costs were higher, a research study suggested. Generic drugs, which have lower copayments,
A new research study found that hormone therapy following breast cancer had significant benefits in terms of greater physical activity, improved cognition, and better cardiovascular
Parsemus Foundation’s Deputy Director attended the International Menopause Society conference last week. The meeting included a wide range of topics related to menopause, and the
About 25% of newly diagnosed breast cancer is ductal carcinoma in situ (DCIS) and it is usually treated with surgery and sometimes radiation. However, only
And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well: